Owner | Filings | Transaction Date | Type of Owner |
---|---|---|---|
Allen Charles W | 0001599502 | Jul-11-2023 | director |
KENTUCKY TECHNOLOGY INC. | 0001976955 | Jul-11-2023 | 10 percent owner |
XU CHERYL | 0001976957 | Jul-11-2023 | director |
FIELD PAUL | 0001976960 | Jul-11-2023 | director |
MILLER TYRONE | 0001976962 | Jul-11-2023 | officer: Chief Financial Officer |
DOW GEOFFREY S | 0001977231 | Jul-11-2023 | director, 10 percent owner, officer: CEO and President |
Florida State University Research Foundation Inc. | 0001977695 | Jul-11-2023 | 10 percent owner |
SMITH BRYAN LEE | 0001978153 | Jul-11-2023 | officer: Chief Medical Officer |
TOOVEY STEPHEN | 0001978935 | Jul-11-2023 | director |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by 60 DEGREES PHARMACEUTICALS, INC.
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001213900-24-009603 ( Act) Size: 6 KB |
Feb-02-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001213900-24-009599 ( Act) Size: 8 KB |
Feb-02-2024 | |
8-K | Document | Current report filing Acc-no: 0001575872-24-000114 (34 Act) Size: 1900 KB |
Feb-02-2024 | 24588069 |
424B4 | Document | Prospectus filed pursuant to Rule 424(b)(4) Acc-no: 0001213900-24-008068 (33 Act) Size: 3685 KB |
Jan-31-2024 | 24580310 |
EFFECT | Document | Acc-no: 9999999995-24-000246 (33 Act) Size: 1 KB | Jan-29-2024 | 24575655 |
8-K | Document | Current report filing Acc-no: 0001213900-24-005352 (34 Act) Size: 290 KB |
Jan-22-2024 | 24549558 |
S-1 | Document | General form of registration statement for all companies including face-amount certificate companies Acc-no: 0001213900-24-005285 (33 Act) Size: 15189 KB |
Jan-22-2024 | 24548831 |
8-K | Document | Current report filing Acc-no: 0001213900-24-003691 (34 Act) Size: 240 KB |
Jan-16-2024 | 24534856 |
DRS | Document | Acc-no: 0001213900-24-003162 (33 Act) Size: 3768 KB | Jan-12-2024 | 24531024 |
SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001140361-23-058055 (34 Act) Size: 77 KB |
Dec-18-2023 | 231492528 |
3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0001140361-23-058049 ( Act) Size: 19 KB |
Dec-18-2023 | |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001213900-23-088610 (34 Act) Size: 7346 KB |
Nov-20-2023 | 231421888 |
NT 10-Q | Document | Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001213900-23-087622 (34 Act) Size: 21 KB |
Nov-15-2023 | 231411540 |
8-K | Document | Current report filing Acc-no: 0001213900-23-083513 (34 Act) Size: 243 KB |
Nov-03-2023 | 231376497 |
8-K | Document | Current report filing Acc-no: 0001013762-23-003541 (34 Act) Size: 319 KB |
Oct-12-2023 | 231322915 |
8-K | Document | Current report filing Acc-no: 0001213900-23-077357 (34 Act) Size: 306 KB |
Sep-18-2023 | 231261545 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001213900-23-070884 (34 Act) Size: 6395 KB |
Aug-25-2023 | 231207792 |
8-K | Document | Current report filing Acc-no: 0001575872-23-001173 (34 Act) Size: 3787 KB |
Jul-17-2023 | 231091715 |
424B4 | Document | Prospectus filed pursuant to Rule 424(b)(4) Acc-no: 0001575872-23-001147 (33 Act) Size: 3346 KB |
Jul-13-2023 | 231086262 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001575872-23-001135 ( Act) Size: 5 KB |
Jul-12-2023 |
Recent 20 filings. View all 60 DEGREES PHARMACEUTICALS, INC. filings
Thanks I look forward to using the product to improve my skin tone
Very good communication and delivery made within the timeframe I was advised of
Huge help thank you for your help .. y'all make it so much easier
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by